The Importance of Regulatory CMC Strategy

Accelerate development using a Quality Target Product Profile

Missed our webinar?

Watch the replay

Having the right Chemistry, Manufacturing, and Controls (CMC) documentation throughout drug development is essential for avoiding pitfalls, ensuring an efficient regulatory review process, and achieving the goals for your product. The key is an early development regulatory strategy that includes CMC.

Join our regulatory CMC webinar to strengthen your knowledge of how regulatory CMC strategies can accelerate the drug development process and become familiar with strategic tools such as the Quality Target Product Profile (QTPP).

Agenda 

10:00  Start and introduction by Hilde Holme

Product Development by Hilde Holme

Quality Target Product Profile by Marianne Ammitzbøll

CMC Documentation & Roadmap by Hilde Foros and Lone Dyrby

Summary by Lone Dyrby​

10:30  Q&A

10:45  End

Speaker bios:

bio_Lone_Dyrby200x200 (2)

Lone Dyrby,

Regulatory Director, Denmark
Lone.Dyrby[@]linkmedical.eu

Lone has 20 years of experience within Regulatory CMC for biologics from the pharmaceutical industry and from the Danish Medicines Agency. Lone has over 10 years of leadership experience.

bio_Hilde_Holm200x (1)

Hilde Holme,

Regulatory Director, Norway
Hilde.Holme[@]linkmedical.eu

Hilde has 25 years of experience in the pharmaceutical industry within research, QC, QA, and regulatory affairs, working extensively within all aspects of regulatory CMC worldwide. Hilde has over 15 years of leadership experience

bio_Marianne_V-Ammitzboll-200x-2

Marianne Ammitzbøll,

Senior Regulatory Manager
Marianne.ammitzboll@linkmedical.eu

Marianne has over 10 years of experience within Regulatory CMC in development and lifecycle projects from various positions in the pharmaceutical industry.

bio_Hilde_Foros-200

Hilde Foros,

Senior Regulatory Manager
Hilde.foros[@]linkmedical.eu

Hilde has more than 20 years of experience in the pharmaceutical industry within various technical roles and regulatory CMC responsibilities, including both pre-marketing and post-marketing CMC.

Need help now?

Contact us

More news

All news
arfolitixorin

First Patient Included and Dosed in the Clinical Phase Ib/II of Arfolitixorin

News
Meet Berit Nautrup Andersen – Safety Director at LINK Medical

Meet Berit Nautrup Andersen – Safety Director

News
Clinical Research Associates High Expertise Local Presence

Clinical Research Associates – High Expertise – Local Presence

News

Get in touch

How can we help you?

Contact us and we will tell you more

Contact us